Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10666191rdf:typepubmed:Citationlld:pubmed
pubmed-article:10666191lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:10666191lifeskim:mentionsumls-concept:C0023448lld:lifeskim
pubmed-article:10666191lifeskim:mentionsumls-concept:C0162638lld:lifeskim
pubmed-article:10666191lifeskim:mentionsumls-concept:C2754998lld:lifeskim
pubmed-article:10666191lifeskim:mentionsumls-concept:C0020843lld:lifeskim
pubmed-article:10666191lifeskim:mentionsumls-concept:C1817697lld:lifeskim
pubmed-article:10666191lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:10666191pubmed:issue4lld:pubmed
pubmed-article:10666191pubmed:dateCreated2000-3-14lld:pubmed
pubmed-article:10666191pubmed:abstractTextPreviously, we demonstrated that B-chronic lymphocytic leukemia (B-CLL) cells could be divided into 2 groups depending on the expression of CD38 by the malignant cells. The 2 groups differed in their signal-transducing capacities initiated by cross-linking of surface IgM; only in CD38-positive cells was an efficient signal delivered, invariably resulting in cell apoptosis. In this study, we investigated the effect of surface IgD cross-linking in 10 patients with CD38-positive B-CLL. Exposure of the malignant cells to goat antihuman delta-chain antibodies (Gadelta-ab) caused [Ca(++)]i mobilization and tyrosine kinase phosphorylation in a manner not different from that observed after goat antihuman mu-chain antibody (Gamu-ab) treatment in vitro. However, Gadelta-ab-treated cells failed to undergo apoptosis and instead displayed prolonged survival in culture and differentiated into plasma cells when rIL2 was concomitantly present. Cross-linking of surface IgD failed to induce proliferation of the malignant cells in vitro. Moreover, treatment with Gadelta-ab did not prevent apoptosis of B-CLL cells induced by Gamu-ab. Collectively, these experiments demonstrated that IgM and IgD expressed by the same cell may deliver opposite signals under particular circumstances and provide some clues for the understanding of the pathophysiology of B-CLL. (Blood. 2000;95:1199-1206)lld:pubmed
pubmed-article:10666191pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10666191pubmed:languageenglld:pubmed
pubmed-article:10666191pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10666191pubmed:citationSubsetAIMlld:pubmed
pubmed-article:10666191pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10666191pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10666191pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10666191pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10666191pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10666191pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10666191pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10666191pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10666191pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10666191pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10666191pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10666191pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10666191pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10666191pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10666191pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10666191pubmed:statusMEDLINElld:pubmed
pubmed-article:10666191pubmed:monthFeblld:pubmed
pubmed-article:10666191pubmed:issn0006-4971lld:pubmed
pubmed-article:10666191pubmed:authorpubmed-author:RossiEElld:pubmed
pubmed-article:10666191pubmed:authorpubmed-author:MalavasiFFlld:pubmed
pubmed-article:10666191pubmed:authorpubmed-author:FerrariniMMlld:pubmed
pubmed-article:10666191pubmed:authorpubmed-author:DongEElld:pubmed
pubmed-article:10666191pubmed:authorpubmed-author:CosulichM EMElld:pubmed
pubmed-article:10666191pubmed:authorpubmed-author:ZupoSSlld:pubmed
pubmed-article:10666191pubmed:authorpubmed-author:MassaraRRlld:pubmed
pubmed-article:10666191pubmed:issnTypePrintlld:pubmed
pubmed-article:10666191pubmed:day15lld:pubmed
pubmed-article:10666191pubmed:volume95lld:pubmed
pubmed-article:10666191pubmed:ownerNLMlld:pubmed
pubmed-article:10666191pubmed:authorsCompleteYlld:pubmed
pubmed-article:10666191pubmed:pagination1199-206lld:pubmed
pubmed-article:10666191pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:10666191pubmed:meshHeadingpubmed-meshheading:10666191...lld:pubmed
pubmed-article:10666191pubmed:meshHeadingpubmed-meshheading:10666191...lld:pubmed
pubmed-article:10666191pubmed:meshHeadingpubmed-meshheading:10666191...lld:pubmed
pubmed-article:10666191pubmed:meshHeadingpubmed-meshheading:10666191...lld:pubmed
pubmed-article:10666191pubmed:meshHeadingpubmed-meshheading:10666191...lld:pubmed
pubmed-article:10666191pubmed:meshHeadingpubmed-meshheading:10666191...lld:pubmed
pubmed-article:10666191pubmed:meshHeadingpubmed-meshheading:10666191...lld:pubmed
pubmed-article:10666191pubmed:meshHeadingpubmed-meshheading:10666191...lld:pubmed
pubmed-article:10666191pubmed:meshHeadingpubmed-meshheading:10666191...lld:pubmed
pubmed-article:10666191pubmed:meshHeadingpubmed-meshheading:10666191...lld:pubmed
pubmed-article:10666191pubmed:meshHeadingpubmed-meshheading:10666191...lld:pubmed
pubmed-article:10666191pubmed:meshHeadingpubmed-meshheading:10666191...lld:pubmed
pubmed-article:10666191pubmed:meshHeadingpubmed-meshheading:10666191...lld:pubmed
pubmed-article:10666191pubmed:meshHeadingpubmed-meshheading:10666191...lld:pubmed
pubmed-article:10666191pubmed:meshHeadingpubmed-meshheading:10666191...lld:pubmed
pubmed-article:10666191pubmed:meshHeadingpubmed-meshheading:10666191...lld:pubmed
pubmed-article:10666191pubmed:meshHeadingpubmed-meshheading:10666191...lld:pubmed
pubmed-article:10666191pubmed:meshHeadingpubmed-meshheading:10666191...lld:pubmed
pubmed-article:10666191pubmed:meshHeadingpubmed-meshheading:10666191...lld:pubmed
pubmed-article:10666191pubmed:meshHeadingpubmed-meshheading:10666191...lld:pubmed
pubmed-article:10666191pubmed:meshHeadingpubmed-meshheading:10666191...lld:pubmed
pubmed-article:10666191pubmed:meshHeadingpubmed-meshheading:10666191...lld:pubmed
pubmed-article:10666191pubmed:meshHeadingpubmed-meshheading:10666191...lld:pubmed
pubmed-article:10666191pubmed:meshHeadingpubmed-meshheading:10666191...lld:pubmed
pubmed-article:10666191pubmed:meshHeadingpubmed-meshheading:10666191...lld:pubmed
pubmed-article:10666191pubmed:year2000lld:pubmed
pubmed-article:10666191pubmed:articleTitleApoptosis or plasma cell differentiation of CD38-positive B-chronic lymphocytic leukemia cells induced by cross-linking of surface IgM or IgD.lld:pubmed
pubmed-article:10666191pubmed:affiliationServizio di Immunologia Clinica, Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. szupo@hp380.ist.unige.itlld:pubmed
pubmed-article:10666191pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10666191pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10666191lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10666191lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10666191lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10666191lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10666191lld:pubmed